Immunotherapy again named ASCO’s ‘Cancer Advance of the Year’ – Healio
|
Immunotherapy again named ASCO's 'Cancer Advance of the Year'
Healio For the second year in a row, ASCO has named immunotherapy as its cancer advance of the year, according to “Clinical Cancer Advances 2017: ASCO's Annual Report on Progress Against Cancer.” … |
